Frequently Asked Questions for RFA-RM-17-022, RFA-RM-17-023, RFA-RM-17-024, & RFA-RM-17-028
The following Frequently Asked Questions (FAQs) are for Use-Inspired Research to Optimize Adherence, Behavior Change Interventions, and Outcomes competing revision (R01, U01, R34) and exploratory/developmental (R21) funding opportunity announcements (RFA-RM-17-022, RFA-RM-17-023, RFA-RM-17-024, & RFA-RM-17-028). For additional background on the SOBC Research Network please see the original FAQs.
SOBC Measures Repository Questions
3. What internet browser should I use to access the SOBC Measures Repository?
Competing Revision Questions
5. Can the parent award be from any of Institute or Center?
8. Would the competing revision award start-up date have to coincide with the parent award timeline?
9. Can we apply for the competing revision if the clinical trial grant has not yet been awarded?
R21 Questions
15. Do you know how many R21s will be funded?
16. Should we propose a clinical trial study as part of an R21 application?
18. For the R21 are interventions based on technologies like smartphones of interest?
General Questions
20. Is the Letter of Intent required?
21. Are we obligated to submit an application if we submit a Letter of Intent?
22. What information is needed in the Letter of Intent and how should we submit it?
23. Are international sites supported?
24. When will successful grants be awarded?
25. What are some example targets for treatment (medical regimen) adherence?
26. Are there sample applications for these opportunities available to view?
This page last reviewed on November 8, 2017